Join Professors Brusselle and Backer as they discuss the concept of disease modification in asthma.
Join Drs. April Armstrong and Lisa Beck for a conversation around the long-term burden and effects of AD. They will discuss the underlying pathophysiology of AD and how early intervention and disease modification may impact disease course.
An infographic to explore the the key roles of CCL17 (TARC) in atopic dermatitis.

Prof. Thomas Bieber explores early intervention and disease modification in atopic dermatitis.

In this video clip from the EAACI 2024 symposium, Dr. Mullol discusses the challenge of defining active nasal disease using an endoscope.